The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Bacteriophages Can Treat and Prevent Pseudomonas aeruginosa Lung Infections
Abstract
Antibiotic-resistant bacteria threaten life worldwide.Although new antibiotics are scarce, the use of bacteriophages, viruses that infect bacteria, is rarely proposed as a means of offsetting this shortage.Doubt also remains widespread about the efficacy of phage therapy despite recent encouraging results.Using a bioluminescent Pseudomonas aeruginosa strain, we monitored and quantified the efficacy of a bacteriophage treatment in mice during acute lung infection.Bacteriophage treatment not only was effective in saving animals from lethal infection, but also was able to prevent lung infection when given 24 h before bacterial infection, thereby extending the potential use of bacteriophages as therapeutic agents to combat bacterial lung infection.Pulmonary infections are one of the major causes of mortality worldwide.Each year it is estimated that ∼2 million children !5 years old die of acute respiratory infections [1].Furthermore, the number of bacterial infections is probably increasing because of resistance to antibiotics.Opportunistic pathogens are becoming increasingly resistant to multiple antibiotics, which urges us to seek other therapeutic approaches, since new antibacterial compounds are scarce [2].Phage therapy is one of several potential therapeutic approaches and has been considered since the late 1980s [3][4][5][6].Bacteriophages are viruses that target and infect only bacteria.Since the middle of the 20th century, studies of bacteriophages have helped to elucidate fun-
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625
Estimates of world-wide distribution of child deaths from acute respiratory infections
Williams, B. G., Gouws, E., Boschi-Pinto, C., Bryce, J., & Dye, C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00170-0 · Cited by 947
Where will new antibiotics come from?
Walsh, C. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro727 · Cited by 755
5500 Phages examined in the electron microscope
Ackermann, H.-W. (2007) · Archives of Virology · doi:10.1007/s00705-006-0849-1 · Cited by 752
Role of TNFα in pulmonary pathophysiology
Mukhopadhyay, S., Hoidal, J. R., & Mukherjee, T. K. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-125 · Cited by 576
Summers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Smith, H. W., & Huggins, M. B. (1983) · Microbiology · doi:10.1099/00221287-129-8-2659 · Cited by 436
Hatfull, G. F. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.004 · Cited by 371
The prospect for bacteriophage therapy in Western medicine
Merril, C. R., Scholl, D., & Adhya, S. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1111 · Cited by 367
Phage therapy: Facts and fiction
Skurnik, M., & Strauch, E. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.09.002 · Cited by 296
Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential
Barrow, P. A., & Soothill, J. S. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01054-8 · Cited by 280
Hanlon, G. W., Denyer, S. P., Olliff, C. J., & Ibrahim, L. J. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.6.2746-2753.2001 · Cited by 244
Quantitative Models of In Vitro Bacteriophage–Host Dynamics and Their Application to Phage Therapy
Cairns, B. J., Timms, A. R., Jansen, V. A. A., Connerton, I. F., & Payne, R. J. H. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000253 · Cited by 227
Applications of bioluminescence imaging to the study of infectious diseases
Hutchens, M., & Luker, G. D. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00995.x · Cited by 221
The future of bacteriophage biology
Campbell, A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1089 · Cited by 220
ACLAME: A CLAssification of Mobile genetic Elements
Leplae, R. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh084 · Cited by 213
Watanabe, R., Matsumoto, T., Sano, G., Ishii, Y., Tateda, K., Sumiyama, Y., Uchiyama, J., Sakurai, S., Matsuzaki, S., Imai, S., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00635-06 · Cited by 206
Bacteriophage Therapy in Humans
Sulakvelidze, A., & Kutter, E. (2004) · Bacteriophages · doi:10.1201/9780203491751.ch14 · Cited by 170
Stress molecules in sepsis and systemic inflammatory response syndrome
Adib‐Conquy, M., & Cavaillon, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.074 · Cited by 162
Bacteriophage therapy for the treatment of infections.
Górski, A., Międzybrodzki, R., Borysowski, J., et al. (2009) · PubMed · Cited by 129
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Reed, E., Ding, L., Gong, J., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.309 · Cited by 121
Heo, Y.-J., Lee, Y.-R., Jung, H.-H., Lee, J., Ko, G., & Cho, Y. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01646-08 · Cited by 116
Boulanger, P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-565-1_13 · Cited by 114
The Role of Flagellin versus Motility in Acute Lung Disease Caused byPseudomonas aeruginosa
Balloy, V., Verma, A., Kuravi, S., Si‐Tahar, M., Chignard, M., & Ramphal, R. (2007) · The Journal of Infectious Diseases · doi:10.1086/518610 · Cited by 84
Self-citationGolshahi, L., Seed, K. D., Dennis, J. J., & Finlay, W. H. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0701 · Cited by 72
Functional Genomic Insights into Acute Lung Injury: Role of Ventilators and Mechanical Stress
Nonas, S. A., Finigan, J. H., Gao, L., & Garcia, J. G. N. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200501-005ac · Cited by 49
Moir, D. T., Di, M., Opperman, T. J., Schweizer, H. P., & Bowlin, T. L. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107304729 · Cited by 40
Finding Homologs in Amino Acid Sequences Using Network BLAST Searches
Ladunga, I. (2009) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0304s25 · Cited by 27
Finding Homologs in Amino Acid Sequences Using Network BLAST Searches
Ladunga, I. (2017) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.34 · Cited by 24
(2004) · CRC Press eBooks · doi:10.1081/e-emgp-120020897 · Cited by 23
渡邊, 良. (2007) · Cited by 19
Cited by
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Wittebole, X., De Roock, S., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.25991 · Cited by 599
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Importance of prophages to evolution and virulence of bacterial pathogens
Fortier, L.-C., & Sekulovic, O. (2013) · Virulence · doi:10.4161/viru.24498 · Cited by 577
Roach, D. R., Leung, C. Y., Henry, M., Morello, E., Singh, D., Di Santo, J. P., Weitz, J. S., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.018 · Cited by 484
Self-citation
Metadata
- Authors
- Debarbieux, L., Leduc, D., Maura, D., Morello, E., Criscuolo, A., Grossi, O., Balloy, V., & Touqui, L.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04
- Volume
- 201
- Issue
- 7
- Pages
- 1096-1104
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2153421727
- Cited by
- 304
- References
- 32
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.